• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在多重比较背景下重新审视贝叶斯药物警戒信号检测方法。

Bayesian pharmacovigilance signal detection methods revisited in a multiple comparison setting.

作者信息

Ahmed Ismaïl, Haramburu Françoise, Fourrier-Réglat Annie, Thiessard Frantz, Kreft-Jais Carmen, Miremont-Salamé Ghada, Bégaud Bernard, Tubert-Bitter Pascale

机构信息

Inserm, U780, 16 Avenue Paul Vaillant Couturier, Villejuif F-94807, France.

出版信息

Stat Med. 2009 Jun 15;28(13):1774-92. doi: 10.1002/sim.3586.

DOI:10.1002/sim.3586
PMID:19360795
Abstract

Pharmacovigilance spontaneous reporting systems are primarily devoted to early detection of the adverse reactions of marketed drugs. They maintain large spontaneous reporting databases (SRD) for which several automatic signalling methods have been developed. A common limitation of these methods lies in the fact that they do not provide an auto-evaluation of the generated signals so that thresholds of alerts are arbitrarily chosen. In this paper, we propose to revisit the Gamma Poisson Shrinkage (GPS) model and the Bayesian Confidence Propagation Neural Network (BCPNN) model in the Bayesian general decision framework. This results in a new signal ranking procedure based on the posterior probability of null hypothesis of interest and makes it possible to derive with a non-mixture modelling approach Bayesian estimators of the false discovery rate (FDR), false negative rate, sensitivity and specificity. An original data generation process that can be suited to the features of the SRD under scrutiny is proposed and applied to the French SRD to perform a large simulation study. Results indicate better performances according to the FDR for the proposed ranking procedure in comparison with the current ones for the GPS model. They also reveal identical performances according to the four operating characteristics for the proposed ranking procedure with the BCPNN and GPS models but better estimates when using the GPS model. Finally, the proposed procedure is applied to the French data.

摘要

药物警戒自发报告系统主要致力于上市药物不良反应的早期发现。它们维护着大型自发报告数据库(SRD),并已开发出多种自动信号检测方法。这些方法的一个共同局限在于,它们无法对生成的信号进行自动评估,因此警报阈值是任意选定的。在本文中,我们建议在贝叶斯通用决策框架下重新审视伽马泊松收缩(GPS)模型和贝叶斯置信传播神经网络(BCPNN)模型。这产生了一种基于感兴趣的零假设的后验概率的新信号排序程序,并使得有可能通过非混合建模方法得出错误发现率(FDR)、假阴性率、灵敏度和特异性的贝叶斯估计量。我们提出了一种能够适应所审查的SRD特征的原始数据生成过程,并将其应用于法国的SRD以进行大规模模拟研究。结果表明,与当前GPS模型的方法相比,所提出的排序程序在FDR方面表现更优。结果还显示,所提出的排序程序在BCPNN和GPS模型的四种操作特征方面表现相同,但使用GPS模型时估计效果更好。最后,将所提出的程序应用于法国的数据。

相似文献

1
Bayesian pharmacovigilance signal detection methods revisited in a multiple comparison setting.在多重比较背景下重新审视贝叶斯药物警戒信号检测方法。
Stat Med. 2009 Jun 15;28(13):1774-92. doi: 10.1002/sim.3586.
2
False discovery rate estimation for frequentist pharmacovigilance signal detection methods.用于频率主义者药物警戒信号检测方法的错误发现率估计
Biometrics. 2010 Mar;66(1):301-9. doi: 10.1111/j.1541-0420.2009.01262.x. Epub 2009 May 4.
3
Pharmacovigilance data mining with methods based on false discovery rates: a comparative simulation study.基于假发现率的药物警戒数据挖掘方法:一项比较性模拟研究。
Clin Pharmacol Ther. 2010 Oct;88(4):492-8. doi: 10.1038/clpt.2010.111. Epub 2010 Sep 1.
4
Comparison of data mining methodologies using Japanese spontaneous reports.使用日本自发报告对数据挖掘方法进行比较。
Pharmacoepidemiol Drug Saf. 2004 Jun;13(6):387-94. doi: 10.1002/pds.964.
5
A comparison of measures of disproportionality for signal detection on adverse drug reaction spontaneous reporting database of Guangdong province in China.中国广东省药品不良反应自发报告数据库中信号检测不均衡性测量方法的比较。
Pharmacoepidemiol Drug Saf. 2008 Jun;17(6):593-600. doi: 10.1002/pds.1601.
6
Data-mining analyses of pharmacovigilance signals in relation to relevant comparison drugs.与相关对照药物相关的药物警戒信号的数据挖掘分析。
Eur J Clin Pharmacol. 2002 Oct;58(7):483-90. doi: 10.1007/s00228-002-0484-z. Epub 2002 Sep 3.
7
A computerized system for signal detection in spontaneous reporting system of Shanghai China.中国上海自发呈报系统中信号检测的计算机化系统。
Pharmacoepidemiol Drug Saf. 2009 Feb;18(2):154-8. doi: 10.1002/pds.1695.
8
Wavelet thresholding with bayesian false discovery rate control.采用贝叶斯错误发现率控制的小波阈值处理
Biometrics. 2005 Mar;61(1):25-35. doi: 10.1111/j.0006-341X.2005.031102.x.
9
Early detection of pharmacovigilance signals with automated methods based on false discovery rates: a comparative study.基于假阳性率的自动化药物警戒信号早期检测:一项比较研究。
Drug Saf. 2012 Jun 1;35(6):495-506. doi: 10.2165/11597180-000000000-00000.
10
Criteria revision and performance comparison of three methods of signal detection applied to the spontaneous reporting database of a pharmaceutical manufacturer.制药商自发报告数据库中三种信号检测方法的标准修订与性能比较
Drug Saf. 2007;30(8):715-26. doi: 10.2165/00002018-200730080-00008.

引用本文的文献

1
Artificial intelligence in pharmacovigilance: a narrative review and practical experience with an expert-defined Bayesian network tool.药物警戒中的人工智能:一项叙述性综述及使用专家定义的贝叶斯网络工具的实践经验
Int J Clin Pharm. 2025 Aug;47(4):932-944. doi: 10.1007/s11096-025-01975-3. Epub 2025 Jul 30.
2
A trajectory-informed model for detecting drug-drug-host interaction from real-world data.一种基于轨迹信息的模型,用于从真实世界数据中检测药物-药物-宿主相互作用。
J Biomed Inform. 2025 May 31;168:104859. doi: 10.1016/j.jbi.2025.104859.
3
A Drug Similarity-Based Bayesian Method for Early Adverse Drug Event Detection.
一种基于药物相似性的贝叶斯早期药物不良事件检测方法。
Drug Saf. 2025 Apr 22. doi: 10.1007/s40264-025-01545-6.
4
A theoretical model for detecting drug interaction with awareness of timing of exposure.一种用于检测药物相互作用并知晓暴露时间的理论模型。
Sci Rep. 2025 Apr 21;15(1):13693. doi: 10.1038/s41598-025-98528-5.
5
Interaction between dipeptidyl-peptidase-4 inhibitors and drugs acting on renin angiotensin aldosterone system for the risk of angioedema: a pharmacovigilance assessment using disproportionality and interaction analyses.二肽基肽酶-4抑制剂与作用于肾素-血管紧张素-醛固酮系统的药物相互作用导致血管性水肿的风险:一项使用不成比例性分析和相互作用分析的药物警戒评估
Diabetol Metab Syndr. 2025 Jan 7;17(1):7. doi: 10.1186/s13098-024-01570-y.
6
Quantitative Structure-Activity Relationship Models to Predict Cardiac Adverse Effects.预测心脏不良反应的定量构效关系模型
Chem Res Toxicol. 2024 Dec 16;37(12):1924-1933. doi: 10.1021/acs.chemrestox.4c00186. Epub 2024 Nov 13.
7
A Precision Mixture Risk Model to Identify Adverse Drug Events in Subpopulations Using a Case-Crossover Design.基于病例交叉设计的精准混合风险模型,用于识别亚人群中的药物不良事件。
Stat Med. 2024 Nov 30;43(27):5088-5099. doi: 10.1002/sim.10216. Epub 2024 Sep 19.
8
An Early Adverse Drug Event Detection Approach with False Discovery Rate Control.一种具有错误发现率控制的早期药物不良事件检测方法。
medRxiv. 2023 Jun 4:2023.05.31.23290792. doi: 10.1101/2023.05.31.23290792.
9
Post-marketing safety of immunomodulatory drugs in multiple myeloma: A pharmacovigilance investigation based on the FDA adverse event reporting system.免疫调节药物在多发性骨髓瘤中的上市后安全性:一项基于美国食品药品监督管理局不良事件报告系统的药物警戒调查。
Front Pharmacol. 2022 Dec 1;13:989032. doi: 10.3389/fphar.2022.989032. eCollection 2022.
10
Challenges and Opportunities of Real-World Data: Statistical Analysis Plan for the Optimise:MS Multicenter Prospective Cohort Pharmacovigilance Study.真实世界数据的挑战与机遇:Optimise:MS多中心前瞻性队列药物警戒研究的统计分析计划
Front Neurol. 2022 Mar 28;13:799531. doi: 10.3389/fneur.2022.799531. eCollection 2022.